The social media upstart got a vote of confidence from top investment and hedge funds amid broader uncertainty on Wall Street.
After a lot of sideways action.
Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.
There have been some successful offerings so far this year, but what are the next offerings to hit the market?
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.